FILING ANALYSIS · FRIDAY, OCTOBER 30
ACTUATE THERAPEUTICS, INC. ACTU — 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
negative
The company received a notice from Nasdaq that its common stock has failed to meet the minimum bid price requirement, and it has 180 days to regain compliance to avoid delisting, which is a significant concern given its current financial situation and previous notice of non-compliance with the minimum market value of listed securities requirement.
How we read impact: we grade every directional call in the open. Impact labels are AI estimates — not investment advice. See the full disclaimer.
Get filings like this every market day
The US SEC filings, UK RNS, EU notices, and Polymarket odds that matter — scored by AI, in one email.
Subscribe free →